|
Project detail: M/s. Vetfar Pharmaceuticals Private Limited (VPPL) was established in the year 2021 for
manufacturing of the Active Pharmaceutical Ingredients (APIs) and API Intermediates
products. The certificate of Incorporation of VPPL is attached as Annexure 1.
Mr. Rahul Nachane is the Managing Director and Mr Rajesh Lawande is the Director and CFO
of the VPPL. Both has rich & varied experience of 36 years and 22 years respectively in
pharmaceutical sector. Under their guidance & leadership, VPPL has excelled in all fields &
surpassed all its previous targets & performance. They are responsible for all the functions,
projects division including appraisal of the projects.
The existing unit of VPPL is located at Plot No. K-37, MIDC Tarapur, Taluka & District –
Palghar, Maharashtra, India – 401506. The total plot area is 2,935 sq. m. The plot no. K-37,
MIDC Tarapur was previously was under possession of M/s Anamayee Pharmachem Pvt. Ltd.
The activity is for expansion in the manufacturing of API & API Intermediates Products by
M/s. Vetfar Pharmaceuticals Private Limited (VPPL). The activity is for enhancement in the
production capacity of API & API Intermediates Products from existing 3.5 TPM to 201 TPM.
As part of the expansion plan, out of the existing four products, three products, with a combined
production capacity of 2.5 TPM, will be discontinued, while one product with a capacity of 1
TPM will be continued post-expansion. In addition, new API and API Intermediates products
will be introduced, resulting in a total production capacity of 201 TPM after the expansion.
The expansion will be done in existing manufacturing unit. Total cost of the project will be
INR 21.36 Crore (Existing: 13.86 Crore & Proposed 7.50 Crore).
An Active Pharmaceutical Ingredient (API) is the ingredient in a pharmaceutical drug that is
biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active
are used in medicine, and the term active substance may be used for natural products. Some
medication products may contain more than one active ingredient. The dosage form for a
pharmaceutical contains the active pharmaceutical ingredient (API), which is the drug itself,
other material that is pharmaceutically inert. Drugs are chosen primarily for their active
ingredients. The Active Pharmaceutical Ingredient (API) is the part of any drug that produces
its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat
different symptoms or act in different ways. In today’s environment there is a need for reliable
supply of high quality pharmaceutical materials, specifically for niche chemical molecules. The
company expects to cater to both domestic and international customers, delivering quality
products. The biggest risk in today’s market is a manufacturer’s supply chain – which is heavily
reliant on imports. VPPL aim is to empower domestic suppliers and start from an early stage
to reduce the countries reliance on imports.
Project Cost: 21.36 cr
Note: please download project document attached to this project for more information.
|
